Al-Masri M, Darwazeh G, El-Ghanem M, Hamdan B, Sughayer M
Chairman, Department of Surgery, King Hussein Cancer Center, Amman, Jordan. Box 1269, Amman 11941, Jordan, Fax + (962 6) 535-3001; E-mail:
Gulf J Oncolog. 2013 Jan;1(13):15-22.
The Memorial Sloan Kettering Cancer Center (MSKCC) breast nomogram has been validated in different populations. In this study, the nomogram was validated for the first time in a Middle East population sample. Although our sample was found to have significant differences from the dataset from which the model was derived, the nomogram proved to be accurate in predicting non sentinel axillary lymph node metastasis. An attempt to use the proportions of involved sentinel lymph nodes instead of absolute numbers of positive and negative sentinel lymph nodes, yet using the same online calculator to predict the probability of non sentinel axillary lymph node metastasis, improved the accuracy, specificity, negative predictive value, and false negative rate.
Axillary clearance is the standard of care in patients with invasive breast cancer and positive sentinel lymph node biopsy. However, in 40-60% of patients, the sentinel lymph nodes are the only involved lymph nodes in the axilla. The Memorial Sloan Kettering Cancer Center (MSKCC) breast nomogram serves to identify a subgroup of patients with low risk of non sentinel lymph node (NSLN) metastasis, in whom axillary lymph node dissection (ALND) could be spared, and thereby, preventing the unwarranted associated morbidity.
The MSKCC nomogram was applied on 91 patients who met the criteria. A modified predictive model was developed by substituting proportions of positive and negative SLN for their absolute numbers. The accuracy was assessed by calculating the area under the receiver-operator characteristic (ROC) curve.
The MSKCC nomogram achieved an area under the ROC curve of 0.76. The area under the curve for the modified predictive model was 0.81. The specificity, negative predictive value, and false negative were 30%, 71%, 20% (MSKCC model) and 55%, 84%, 17% (modified model) at 20% predicted probability cut-off values.
Although differences existed in characteristics of our breast cancer population, and in the methods of sentinel lymph node metastasis detection, the MSKCC model proved to be accurate. An attempt to replace the number of positive and negative SLNs with proportions in the MSKCC model raised the accuracy but did not achieve statistical significance (p = 0.09).
Breast cancer, Sentinel lymph node, Non sentinel lymph node, Axillary clearance, Predictive model.
纪念斯隆凯特琳癌症中心(MSKCC)的乳腺癌列线图已在不同人群中得到验证。在本研究中,该列线图首次在中东人群样本中得到验证。尽管我们的样本与推导该模型所用的数据集存在显著差异,但该列线图在预测非前哨腋窝淋巴结转移方面被证明是准确的。尝试使用受累前哨淋巴结的比例而非前哨淋巴结阳性和阴性的绝对数量,同时使用相同的在线计算器来预测非前哨腋窝淋巴结转移的概率,提高了准确性、特异性、阴性预测值和假阴性率。
腋窝清扫是浸润性乳腺癌且前哨淋巴结活检阳性患者的标准治疗方法。然而,在40% - 60%的患者中,前哨淋巴结是腋窝中唯一受累的淋巴结。纪念斯隆凯特琳癌症中心(MSKCC)的乳腺癌列线图用于识别非前哨淋巴结(NSLN)转移低风险的患者亚组,这些患者可避免腋窝淋巴结清扫(ALND),从而预防不必要的相关并发症。
将MSKCC列线图应用于9名符合标准的患者。通过用阳性和阴性前哨淋巴结的比例替代其绝对数量,开发了一种改良的预测模型。通过计算受试者操作特征(ROC)曲线下面积来评估准确性。
MSKCC列线图的ROC曲线下面积为0.76。改良预测模型的曲线下面积为0.81。在预测概率截断值为20%时,特异性、阴性预测值和假阴性在MSKCC模型中分别为3%、71%、20%,在改良模型中分别为55%、84%、17%。
尽管我们的乳腺癌人群特征以及前哨淋巴结转移检测方法存在差异,但MSKCC模型被证明是准确的。尝试在MSKCC模型中用比例替代阳性和阴性前哨淋巴结的数量提高了准确性,但未达到统计学意义(p = 0.09)。
乳腺癌;前哨淋巴结;非前哨淋巴结;腋窝清扫;预测模型